Senestech, Inc. (NASDAQ:SNES – Get Free Report) was the target of a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 21,680 shares, a decline of 39.9% from the January 29th total of 36,090 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily volume of 69,813 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 69,813 shares, the short-interest ratio is currently 0.3 days. Approximately 0.4% of the company’s stock are short sold.
Senestech Trading Down 1.3%
NASDAQ:SNES opened at $2.25 on Friday. Senestech has a 52 week low of $1.30 and a 52 week high of $6.24. The firm has a 50-day moving average price of $2.11 and a two-hundred day moving average price of $3.22. The company has a debt-to-equity ratio of 0.01, a quick ratio of 14.73 and a current ratio of 15.75. The firm has a market cap of $11.75 million, a price-to-earnings ratio of -0.62 and a beta of 0.21.
Insider Buying and Selling
In related news, major shareholder Glenbrook Capital Management acquired 34,613 shares of the firm’s stock in a transaction on Thursday, February 19th. The stock was purchased at an average cost of $2.40 per share, with a total value of $83,071.20. Following the acquisition, the insider owned 704,211 shares of the company’s stock, valued at approximately $1,690,106.40. This trade represents a 5.17% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders purchased 173,954 shares of company stock worth $367,303. Insiders own 5.29% of the company’s stock.
Institutional Trading of Senestech
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Senestech in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold”.
View Our Latest Report on Senestech
Senestech Company Profile
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Featured Stories
- Five stocks we like better than Senestech
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- Read this or regret it forever
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
